// App-Quantinova.ai

67 : The contribution of germline DNA damage response mutations on prostate cancer risk and prognosis—A UK Biobank whole-exome analysis.

Researchers

Presenter

  • Niedzica Camacho

Principal Investigators

  • Athena Matakidou

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved